Page last updated: 2024-08-16

proguanil and Breast Neoplasms

proguanil has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Alves Dos Santos, R; de Oliveira Silva, E; Dos Santos Gonçalves, N; Jacometti Cardoso Furtado, NA	1
Gruber, DM; Huber, JC; Sator, MO	1

Reviews

1 review(s) available for proguanil and Breast Neoplasms

Article	Year
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Other Studies

2 other study(ies) available for proguanil and Breast Neoplasms

Article	Year
Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite. European journal of drug metabolism and pharmacokinetics, 2016, Volume: 41, Issue:5 Topics: Animals; Antimalarials; Atovaquone; Breast Neoplasms; Caenorhabditis elegans; Cell Line; Cell Line, Tumor; Female; Fibroblasts; Fungi; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Metabolic Detoxication, Phase I; Proguanil	2016
Hormone replacement therapy and breast cancer. Lancet (London, England), 1997, Nov-29, Volume: 350, Issue:9091 Topics: Atovaquone; Bias; Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Female; Humans; Naphthoquinones; Proguanil	1997

Article

Year

Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.

European journal of drug metabolism and pharmacokinetics, 2016, Volume: 41, Issue:5

Topics: Animals; Antimalarials; Atovaquone; Breast Neoplasms; Caenorhabditis elegans; Cell Line; Cell Line, Tumor; Female; Fibroblasts; Fungi; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Metabolic Detoxication, Phase I; Proguanil

2016

Hormone replacement therapy and breast cancer.

Lancet (London, England), 1997, Nov-29, Volume: 350, Issue:9091

Topics: Atovaquone; Bias; Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Female; Humans; Naphthoquinones; Proguanil

1997